Carglumic	MISC
acid	O
is	O
an	O
orphan	O
drug	O
,	O
marketed	O
by	O
Orphan	ORGANIZATION
Europe	ORGANIZATION
under	O
thetrade	O
name	O
Carbaglu	PERSON
.	O
Carglumic	O
acid	O
is	O
used	O
for	O
the	O
treatment	O
ofhyperammonaemia	O
in	O
patients	O
with	O
_	O
N	O
_	O
-	O
acetylglutamate	O
synthasedeficiency	O
.	O
The	O
initial	O
daily	SET
dose	O
ranges	O
from	O
100	NUMBER
to	NUMBER
250	NUMBER
mg/kg	O
,	O
adjusted	O
thereafter	O
to	O
maintain	O
normal	O
plasma	O
levels	O
of	O
ammonia	O
.	O
